Evaluation of Hexadecyloxypropyl-9- <i>R</i> -[2-(Phosphonomethoxy)Propyl]-Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections — George R. Painter (2007) | RDL Network
Evaluation of Hexadecyloxypropyl-9- <i>R</i> -[2-(Phosphonomethoxy)Propyl]-Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections
George R. Painter, Merrick R. Almond, Lawrence C. Trost, Bernhard Lampert, Johan Neyts, De Clercq Erik, Brent E. Korba, Kathy A. Aldern, James R. Beadle, Karl Y. Hostetler
Discussion(0)
No comments yet. Be the first to comment.